HCQ Trials On COVID-19 Patients Halted By WHO After A Study Highlighted Side Effects

The World Health Organisation has temporarily halted the clinical trial of malaria drug, Hydroxychloroquine, for the treatment of COVID-19. This decision was taken after Lancet published a study that said that HCQ was linked to an increased risk of death and heart ailments.